Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Oral Semaglutide and Cardiovascular Outcomes in Type 2 Diabetes.

× No keyword cloud information.

5 in total

1. Cardiovascular safety and efficacy of metformin-SGLT2i versus metformin-sulfonylureas in type 2 diabetes: systematic review and meta-analysis of randomized controlled trials.

Authors: Desye Gebrie; Desalegn Getnet; Tsegahun Manyazewal
Journal: Sci Rep Date: 2021-01-08 Impact factor: 4.379

Review 2. Oral GLP-1 analogue: perspectives and impact on atherosclerosis in type 2 diabetic patients.

Authors: José Francisco Kerr Saraiva; Denise Franco
Journal: Cardiovasc Diabetol Date: 2021-12-15 Impact factor: 9.951

3. Cost-Utility Analysis of Once-Weekly Semaglutide, Dulaglutide, and Exenatide for Type 2 Diabetes Patients Receiving Metformin-Based Background Therapy in China.

Authors: Shanshan Hu; Shuowen Wang; Chendong Qi; Shengying Gu; Chenyang Shi; Lin Mao; Guorong Fan
Journal: Front Pharmacol Date: 2022-02-18 Impact factor: 5.810

Review 4. Management of type 2 diabetes: consensus of diabetes organizations.

Authors: Elaena Quattrocchi; Tamara Goldberg; Nino Marzella
Journal: Drugs Context Date: 2020-01-27

5. Metformin-Insulin versus Metformin-Sulfonylurea Combination Therapies in Type 2 Diabetes: A Comparative Study of Glycemic Control and Risk of Cardiovascular Diseases in Addis Ababa, Ethiopia.

Authors: Desye Gebrie; Tsegahun Manyazewal; Dawit A Ejigu; Eyasu Makonnen
Journal: Diabetes Metab Syndr Obes Date: 2021-07-24 Impact factor: 3.168

5 in total